Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa05161 | Hepatitis B | 154/6408 | 162/8135 | 0.00000000423 | 0.000000118 | 0.0000000453 | 154 | RABC39 | |
| KEGG | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 182/6408 | 194/8135 | 0.0000000046 | 0.000000118 | 0.0000000454 | 182 | RABC39 | |
| KEGG | hsa04010 | MAPK signaling pathway | 268/6408 | 294/8135 | 0.00000000589 | 0.000000141 | 0.0000000541 | 268 | RABC39 | |
| KEGG | hsa04142 | Lysosome | 127/6408 | 132/8135 | 0.00000000878 | 0.000000196 | 0.0000000752 | 127 | RABC39 | |
| KEGG | hsa05171 | Coronavirus disease - COVID-19 | 214/6408 | 232/8135 | 0.0000000152 | 0.000000317 | 0.000000122 | 214 | RABC39 | |
| KEGG | hsa05164 | Influenza A | 161/6408 | 171/8135 | 0.0000000172 | 0.000000337 | 0.00000013 | 161 | RABC39 | |
| KEGG | hsa04210 | Apoptosis | 130/6408 | 136/8135 | 0.0000000239 | 0.000000438 | 0.000000168 | 130 | RABC39 | |
| KEGG | hsa00562 | Inositol phosphate metabolism | 73/6408 | 73/8135 | 0.0000000249 | 0.000000438 | 0.000000168 | 73 | RABC39 | |
| KEGG | hsa05170 | Human immunodeficiency virus 1 infection | 196/6408 | 212/8135 | 0.000000038 | 0.000000635 | 0.000000244 | 196 | RABC39 | |
| KEGG | hsa04014 | Ras signaling pathway | 213/6408 | 232/8135 | 0.0000000484 | 0.00000077 | 0.000000296 | 213 | RABC39 | |
| KEGG | hsa04218 | Cellular senescence | 147/6408 | 156/8135 | 0.0000000627 | 0.000000951 | 0.000000366 | 147 | RABC39 | |
| KEGG | hsa04141 | Protein processing in endoplasmic reticulum | 160/6408 | 171/8135 | 0.0000000711 | 0.00000103 | 0.000000397 | 160 | RABC39 | |
| KEGG | hsa04932 | Non-alcoholic fatty liver disease | 146/6408 | 155/8135 | 0.0000000754 | 0.00000104 | 0.000000399 | 146 | RABC39 | |
| KEGG | hsa05166 | Human T-cell leukemia virus 1 infection | 204/6408 | 222/8135 | 0.0000000776 | 0.00000104 | 0.000000399 | 204 | RABC39 | |
| KEGG | hsa04659 | Th17 cell differentiation | 104/6408 | 108/8135 | 0.000000184 | 0.00000235 | 0.000000902 | 104 | RABC39 | |
| KEGG | hsa04120 | Ubiquitin mediated proteolysis | 134/6408 | 142/8135 | 0.00000019 | 0.00000235 | 0.000000902 | 134 | RABC39 | |
| KEGG | hsa05220 | Chronic myeloid leukemia | 75/6408 | 76/8135 | 0.000000263 | 0.00000313 | 0.00000121 | 75 | RABC39 | |
| KEGG | hsa05214 | Glioma | 74/6408 | 75/8135 | 0.00000033 | 0.0000038 | 0.00000146 | 74 | RABC39 | |
| KEGG | hsa04668 | TNF signaling pathway | 107/6408 | 112/8135 | 0.000000495 | 0.00000551 | 0.00000212 | 107 | RABC39 | |
| KEGG | hsa04152 | AMPK signaling pathway | 114/6408 | 120/8135 | 0.000000547 | 0.00000589 | 0.00000227 | 114 | RABC39 | |
| KEGG | hsa04380 | Osteoclast differentiation | 121/6408 | 128/8135 | 0.000000573 | 0.00000598 | 0.0000023 | 121 | RABC39 | |
| KEGG | hsa04935 | Growth hormone synthesis, secretion and action | 113/6408 | 119/8135 | 0.000000663 | 0.00000671 | 0.00000258 | 113 | RABC39 | |
| KEGG | hsa04630 | JAK-STAT signaling pathway | 150/6408 | 162/8135 | 0.00000124 | 0.0000121 | 0.00000465 | 150 | RABC39 | |
| KEGG | hsa04144 | Endocytosis | 226/6408 | 251/8135 | 0.00000127 | 0.0000121 | 0.00000465 | 226 | RABC39 | |
| KEGG | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 86/6408 | 89/8135 | 0.00000138 | 0.0000128 | 0.00000492 | 86 | RABC39 | |
| KEGG | hsa05165 | Human papillomavirus infection | 293/6408 | 331/8135 | 0.00000171 | 0.0000154 | 0.00000593 | 293 | RABC39 | |
| KEGG | hsa04625 | C-type lectin receptor signaling pathway | 99/6408 | 104/8135 | 0.00000238 | 0.0000209 | 0.00000804 | 99 | RABC39 | |
| KEGG | hsa05145 | Toxoplasmosis | 106/6408 | 112/8135 | 0.00000252 | 0.0000216 | 0.00000828 | 106 | RABC39 | |
| KEGG | hsa05160 | Hepatitis C | 145/6408 | 157/8135 | 0.00000286 | 0.0000239 | 0.00000918 | 145 | RABC39 | |
| KEGG | hsa04936 | Alcoholic liver disease | 132/6408 | 142/8135 | 0.00000303 | 0.0000247 | 0.00000949 | 132 | RABC39 |